Adapted from BMJ 4 Nov 2023
HRT prescriptions were given to 29% more women between 2022 and 2023 in England.
My comment: This increase could be due to the increased publicity brought about by Davina McCall and Mariela Frostrup through the media.
There were significant geographical differences. Twice as many women in affluent areas were prescribed the medication compared to women in the most deprived areas.
In a recent Pulse educational article I was reading very recently, I was dismayed to see that the author, considered an “expert” in the subject, was very strongly of the opinion that GPs should only prescribe HRT for women who were suffering symptoms of the menopause. It had been my practice for many years to discuss the pros and cons of HRT with regards to the patient in front of me, so that she could decide for herself whether taking it to suppress symptoms on the medium term or taking it long term to reduce osteoporosis, cardiovascular disease, genito-urinary problems, and bowel cancer was something that she wanted to do.
The very helpful site: Menopause Matters, has useful information to guide patients as to the pros and cons of the use of HRT and the types of formulation that are best for individual circumstances.
Diabetes Diet 